Held once every ten years, the Decennial Conference reviews the advances of the previous decade and the opportunities and trends for the fields of healthcare epidemiology, infectious diseases, and infection prevention and control for the future.
The latest data from a national surveillance system that monitors foodborne bacteria for antibiotic resistance shows rising resistance to commonly used drugs to treat Salmonella infections.
According to an article published in Science resistance to common antibiotics used in livestock production is rising in food-producing animals in the developing world.
The World Health Organization conducted a study on drug-resistant HIV in 12 countries over the past 4 years and have found that more than 10% of adults being treated for HIV have developed a drug-resistant strain within these 12 countries.
Multi-drug resistant E. coli strains were found in healthy women showing no symptoms of urinary tract infections. This led researchers to reevaluate the clinical significance of bacteria in urine without symptoms and the possibility of pandemic strains.
The Indian government has banned the use of “last hope” antibiotics on farms. This article chronicles the events leading up the ban, as well as their own investigative story into Indian farms that revealed the wide use of these antibiotics to fatten livestock.
This document outlines how Wawles will address the risks of the development and spread of antimicrobial resistance in animals and the environment. It discusses best agriculture best practices that align with antimicrobial stewardship.
The Welsh government released a five-year plan to decrease antimicrobial resistance in their livestock population. With an emphasis on prevention and judicious use of antimicrobials, the Welsh government aims to use antimicrobials wisely to preserve their effectiveness.
To help combat antimicrobial resistance, the World Health Organization (WHO) launched the AWaRe portal which divides antibiotics into three groups – Access, Watch and Reserve.
Researchers investigated the mode of action of a new class of antibiotics that is highly effective against multidrug-resistant pathogens. Fibupeptides impair the energy supply to the bacterial cell, consequently causing their death.